SK Life Science Revenue and Competitors
Estimated Revenue & Valuation
- SK Life Science's estimated annual revenue is currently $70.6M per year.
- SK Life Science's estimated revenue per employee is $235,170
Employee Data
- SK Life Science has 300 Employees.
- SK Life Science grew their employee count by 3% last year.
SK Life Science's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
2 | VP Medical Affairs SKLife Science | Reveal Email/Phone |
3 | VP Corporate Center | Reveal Email/Phone |
4 | Head Information Technology | Reveal Email/Phone |
5 | VP Global Head Quality | Reveal Email/Phone |
6 | Senior Director, Medical Affairs | Reveal Email/Phone |
7 | Associate Director Commercial Learning and Development | Reveal Email/Phone |
8 | Director | Reveal Email/Phone |
9 | Director, Pharmacovigilance | Reveal Email/Phone |
10 | GxP Director-QA | Reveal Email/Phone |
SK Life Science Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 27 | 29% | N/A | N/A |
#2 | $35.8M | 156 | 6% | N/A | N/A |
#3 | $5.4M | 27 | 23% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 72 | 50% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 45 | 15% | N/A | N/A |
#8 | $10.3M | 63 | 34% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is SK Life Science?
SK life science is a subsidiary of SK biopharmaceuticals, focused on developing and bringing treatments for disorders of the central nervous system (CNS) to market. Both are a part of the global conglomerate SK Group, the second largest company in Korea . SK life science is growing quickly in the U.S., with headquarters in Fair Lawn, New Jersey. SK life science has a pipeline of six products in development for the treatment of CNS disorders including epilepsy, sleep disorder and attention deficit hyperactivity disorder, among others. The company's lead product is cenobamate, an investigational compound that is being studied as a potential treatment option for patients with epilepsy.
keywords:N/A
N/A
Total Funding
300
Number of Employees
$70.6M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SK Life Science News
SK Life Science, a U.S. subsidiary of SK Biopharm, is testing cenobamate (U.S. brand: Xcopri), an epilepsy drug, to treat people aged 18 or...
Latest life sciences news: COVID-19 nasal spray; disease reversal; ... South Korea's SK Bioscience is leading clinical development,...
SK Biopharmaceuticals and its U.S. subsidiary SK life science are pharmaceutical companies focused on the research, development and...
This article is sponsored by SK Life Science Inc. ... poorer health-related quality of life (QOL) and higher rates of comorbidities than the general ...
Other Companies in Fair Lawn
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $274.6M | 674 | 0% | N/A |
#2 | $733.7M | 5241 | 4% | N/A |
#3 | $8686.5M | 25325 | 9% | N/A |